Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia | Zendy

Christina M. Parrinello | Zendy; A. Richey Sharrett | Zendy; Nisa M. Maruthur | Zendy; Richard M. Bergenstal | Zendy; Morgan E. Grams | Zendy; Josef Coresh | Zendy; Elizabeth Selvin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia

Author(s) -

Christina M. Parrinello,

A. Richey Sharrett,

Nisa M. Maruthur,

Richard M. Bergenstal,

Morgan E. Grams,

Josef Coresh,

Elizabeth Selvin

Publication year - 2015

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc15-1360

Subject(s) - medicine , diabetes mellitus , biomarker , fructosamine , odds ratio , proportional hazards model , endocrinology , biochemistry , chemistry

We compared levels and associations of traditional (fasting glucose, HbA1c) and nontraditional (fructosamine, glycated albumin, and 1,5-anhydroglucitol [1,5-AG]) biomarkers of hyperglycemia with incident cardiovascular disease (CVD), incident end-stage renal disease (ESRD), and prevalent retinopathy in black and white adults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research